HSA, Malaysia’s MDA launch joint effort to streamline medical device regulation

Both agencies will use each other’s reviews to speed up device approvals.

Singapore’s Health Science Authority (HSA) and Malaysia’s Medical Devices Authority (MDA) have launched the first regulatory reliance pilot for medical devices.

The six-month pilot of the Medical Device Regulatory Reliance Programme, running from 1 September 2025 to 28 February 2026, aims to expedite market access for Class B, C, and D medical devices by reducing duplicate regulatory reviews and leveraging each other's approvals.

The reliance programme is expected to help manufacturers in Singapore with up to 30% shorter review times across multiple device categories.

Such efficiency gains are expected to encourage more cross-border filings, reduce time-to-market, and improve patient access to new technologies.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia